
Letter from Aaron J. Kowalski, PhD, CEO of Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes research and advocacy organization, to Robert F. Kennedy Jr., United States Secretary of Health and Human Services (HHS)
Dear Secretary Kennedy, Congratulations on your confirmation as United States Secretary of Health and Human Services. On behalf of the…

A behind-the-scenes look at DIAGNODE-3: Phase 3 clinical trials of Diamyd® for T1D
DIAGNODE-3 is a phase 3 clinical trial of the disease-modifying therapy Diamyd® that aims to preserve insulin-producing beta cells.

Cell therapy first: transplanted islets working without immunosuppressives
Today, Sana Biotechnology released significant clinical data: the first person with type 1 diabetes (T1D) who received deceased donor islets…

Clinical Trials in Action: Aiedan’s Story
Meet Aiedan, a participant in the T1D RELAY clinical trial that aims to preserve insulin production in those newly diagnosed…

Reflecting on 50 Years with Type 1 Diabetes
Phyllis Kaplan, who has lived with type 1 diabetes for 50 years, reflects on progress made thanks to Breakthrough T1D.

Orlando Brown, Jr. nominated for Walter Payton NFL Man of the Year Award
Orlando Brown, Jr. has been nominated for the Man of the Year Award in recognition of his outreach work with…

Celebrating the holidays with type 1 diabetes
Tips to help you celebrate the holidays with type 1 diabetes. Plan ahead and do a bit of adjusting so…

Meet Paola Reynoso, a hero for the Spanish-speaking T1D community
Paola Reynoso has been integral in bringing together the T1D Spanish-speaking community.

Meet Orlando Brown, Jr., a hero for T1D advocacy
Orlando Brown, Jr.'s commitment to type 1 diabetes (T1D) advocacy stems from his family’s journey with the disease.

Moving T1D forward through advocacy
Breakthrough T1D Chief Global Advocacy Officer Lynn Starr discusses how type 1 diabetes advocacy drives our mission progress forward...faster.